Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (ACST)

14 filings reported holding ACST - Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (ACST) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1.16M shares of 15.5M outstanding shares and own 7.48% of the company stock.
Largest 10 shareholders include AIGH Capital Management LLC (641K shares), BANK OF AMERICA CORP /DE/ (495K shares), RENAISSANCE TECHNOLOGIES LLC (16.1K shares), Tower Research Capital LLC (TRC) (2.73K shares), NATIONAL BANK OF CANADA /FI/ (2.72K shares), MORGAN STANLEY (1.88K shares), Royal Bank of Canada (543 shares), Activest Wealth Management (104 shares), UBS Group AG (28 shares), and Federation des caisses Desjardins du Quebec (28 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.